Advertisement

Reactions Weekly

, Volume 1658, Issue 1, pp 247–247 | Cite as

Infliximab

Various toxicities: case report
Case report
  • 27 Downloads

Reference

  1. Cardile S, et al. Lack of efficacy of infliximab in the treatment of primary sclerosing cholangitis in inflammatory bowel diseases in childhood. European Journal of Gastroenterology and Hepatology 29: 736, No. 6, Jun 2017. Available from: URL: http://doi.org/10.1097/MEG.0000000000000847 - ItalyCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Personalised recommendations